News

Study suggests lithium may decrease risk of developing dementia

Researchers have identified a link which suggests that lithium could decrease the risk of developing dementia, which affects nearly one million people in the UK. Read more

Personalised blood test can detect persistent lung cancer

Patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test that is performed after treatment, according to new research.Read more

Exploring how inflammation affects cognitive performance in people with depression

Research has found that inflammation may influence cognitive problems for people with depression, highlighting a new target to improve treatment.Read more

Cambridge Professors receive NIHR Senior Investigator awards

Professor Emanuele Di Angelantonio and Professor Tamsin Ford have been newly-appointed as Senior Investigators for the NIHR. Read more

Cambridge CRF receives new funding boost for delivery of early stage clinical research

The NIHR Cambridge Clinical Research Facility (CRF) has been awarded new funding to support its research over the next 5 years.Read more

Cancer drug gives hope in treating heart attacks

Cambridge researchers have found a drug used to treat cancer could help with heart attack recovery.Read more

1,000 Covid patients sign up to UK drug trial

A study funded by the NIHR Cambridge BRC, has enrolled a thousand Covid patients to find new treatments for the long term consequences of the disease.Read more

Artificial pancreas proves ‘life-changing’ for very young children with type 1 diabetes and their families

An artificial pancreas developed by Cambridge researchers and supported by the NIHR Cambridge BRC, has found it is both safe to use and more effective at managing blood sugar levels in young children than current technology.

Read more

Award given to build data ‘bridge’ that could revolutionise precision medicine

Funding awarded by UK Research and Innovation as part of the DARE UK programme, to develop and test a health data ‘bridge’ for researchers to work with combined data.Read more

Consensus opens door to worldwide improvements in breast cancer radiotherapy treatment

A panel of European experts and patients has identified a way to achieve major changes in the way radiotherapy treatment for breast cancer patients is delivered around the world.Read more

NICE prostate guidelines updated based on Cambridge research

A Cambridge developed model to risk-categorise prostate cancer has been added to the NICE guidelines.Read more

New ground-breaking research that is a potential game-changer for diagnosis and treatment of undiagnosed rare disease patients

In a world-first, new research has shown that whole genome sequencing can uncover new diagnoses for patients with rare diseases. Read more

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

An international study has revealed that IBS symptoms may be caused by the same biological processes in conditions such as anxiety.Read more

New research shows how our brain uses nutritional state to control growth and age at puberty

Rearchers have discovered how a receptor in the brain detects the nutritional state of the body and regulates the timing of puberty and rate of growth in children.Read more

Scientists identify the cause of Alzheimer’s progression in the brain

New research has used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought.Read more

Call for 10,000 volunteers in the UK to take part in international breast cancer study

NIHR Cambridge Biomedical Research Centre is supporting a large international study to test out a more personalised way to screen for breast cancer and detect it sooner.Read more

Positive phase 3 results reported in trial for new Covid-19 vaccine

A clinical trial supported by the NIHR Cambridge BRC for a new vaccine against COVID-19 has received positive Phase 3 results.Read more

Professor Rebecca Fitzgerald awarded The Don Listwin award

Congratulations to Professor Rebecca Fitzgerald, who has received the Don Listwin Award for Outstanding Contribution to Cancer Early Detection.Read more

Could a cancer drug be key to helping patients recover from a heart attack?

A trial is underway in Cambridge to investigate whether a cancer drug could improve the recovery of heart attack patients, by targeting the immune system.Read more

Supporting National Inclusion Week

National Inclusion Week campaign aims to celebrate everyday inclusion in all its forms. Read more